Literature DB >> 8356908

Role of glutathione in cellular resistance to alkylating agents.

O M Colvin1, H S Friedman, M P Gamcsik, C Fenselau, J Hilton.   

Abstract

Both elevated glutathione levels and increased activity of the enzyme glutathione S-transferase have been associated with the resistance of cells to alkylating agents. We have demonstrated that one mechanism of this resistance is the inactivation of the alkylating agents by conjugation with glutathione. This conjugation can be catalyzed by glutathione S-transferase. For the nitrogen mustard agents we have studied, both the spontaneous and enzyme catalyzed reactions proceed through the aziridinium intermediates of the alkylating agents, and the alpha isoenzymes of GST are involved. In a study of cyclophosphamide resistant medulloblastoma cell lines elevated cellular concentrations of glutathione correlated well with the resistance of the cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356908     DOI: 10.1016/0065-2571(93)90006-y

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  11 in total

1.  SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.

Authors:  Monika D Polewski; Rosyli F Reveron-Thornton; Gregory A Cherryholmes; Georgi K Marinov; Karen S Aboody
Journal:  Stem Cells Dev       Date:  2017-07-27       Impact factor: 3.272

2.  Overexpression of the regulatory subunit of gamma-glutamylcysteine synthetase in HeLa cells increases gamma-glutamylcysteine synthetase activity and confers drug resistance.

Authors:  S R Tipnis; D G Blake; A G Shepherd; L I McLellan
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  A Genetic Map of the Response to DNA Damage in Human Cells.

Authors:  Michele Olivieri; Tiffany Cho; Alejandro Álvarez-Quilón; Kejiao Li; Matthew J Schellenberg; Michal Zimmermann; Nicole Hustedt; Silvia Emma Rossi; Salomé Adam; Henrique Melo; Anne Margriet Heijink; Guillermo Sastre-Moreno; Nathalie Moatti; Rachel K Szilard; Andrea McEwan; Alexanda K Ling; Almudena Serrano-Benitez; Tajinder Ubhi; Sumin Feng; Judy Pawling; Irene Delgado-Sainz; Michael W Ferguson; James W Dennis; Grant W Brown; Felipe Cortés-Ledesma; R Scott Williams; Alberto Martin; Dongyi Xu; Daniel Durocher
Journal:  Cell       Date:  2020-07-09       Impact factor: 41.582

4.  Substituents on quinone methides strongly modulate formation and stability of their nucleophilic adducts.

Authors:  Emily E Weinert; Ruggero Dondi; Stefano Colloredo-Melz; Kristen N Frankenfield; Charles H Mitchell; Mauro Freccero; Steven E Rokita
Journal:  J Am Chem Soc       Date:  2006-09-13       Impact factor: 15.419

Review 5.  Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug development.

Authors:  Jaishri Blakeley; Jana Portnow
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-10-23       Impact factor: 4.481

6.  Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.

Authors:  Monika D Polewski; Rosyli F Reveron-Thornton; Gregory A Cherryholmes; Georgi K Marinov; Kaniel Cassady; Karen S Aboody
Journal:  Mol Cancer Res       Date:  2016-09-22       Impact factor: 5.852

7.  Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication.

Authors:  Majid Shohrati; Mostafa Ghanei; Navvab Shamspour; Fatemeh Babaei; Majid Norozi Abadi; Mahvash Jafari; Ali Amini Harandi; Amini Harandi Ali
Journal:  Lung       Date:  2009-10-28       Impact factor: 2.584

Review 8.  The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.

Authors:  Ashkan Emadi; Judith E Karp
Journal:  Pharmacogenomics       Date:  2012-08       Impact factor: 2.533

Review 9.  Ovarian cancer stem cells: a new target for cancer therapy.

Authors:  Qinglei Zhan; Chunmei Wang; Saiming Ngai
Journal:  Biomed Res Int       Date:  2013-01-30       Impact factor: 3.411

10.  A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.

Authors:  John Murren; Manuel Modiano; Shivaani Kummar; Caroline Clairmont; Merrill Egorin; Edward Chu; Mario Sznol
Journal:  Invest New Drugs       Date:  2005-03       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.